In addition, cAMP-hydrolyzing PDE inhibitors, such as dipyridamole and cilostazol, increased cAMP levels and potentiated statin-induced apoptosis in hematological disease (Longo et al., 2020). This evidence concerns the gene ALDH7A1 and hematologic disorder.